Sawaf Aziz (CIK 1961289) reported 10 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-24). Recent activity: Sell TBPH (204,966 shares), Sell TBPH (108,436 shares), Sell TBPH (23,439 shares), Sell TBPH (8,112 shares), Sell TBPH (8,670 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-24 | Theravance Biopharma, Inc. (TBPH) | SVP & CHIEF FINANCIAL OFFICER | Sell | 204,966 | $0 |
| 2026-09-24 | Theravance Biopharma, Inc. (TBPH) | SVP & CHIEF FINANCIAL OFFICER | Sell | 108,436 | $0 |
| 2026-09-24 | Theravance Biopharma, Inc. (TBPH) | SVP & CHIEF FINANCIAL OFFICER | Sell | 23,439 | $0 |
| 2026-08-24 | Theravance Biopharma, Inc. (TBPH) | SVP & CHIEF FINANCIAL OFFICER | Sell | 8,112 | $137,498 |
| 2026-05-22 | Theravance Biopharma, Inc. (TBPH) | SVP & CHIEF FINANCIAL OFFICER | Sell | 8,670 | $143,488 |
| 2026-04-03 | Theravance Biopharma, Inc. (TBPH) | SVP & CHIEF FINANCIAL OFFICER | Buy | 37,500 | $0 |
| 2026-02-24 | Theravance Biopharma, Inc. (TBPH) | SVP & CHIEF FINANCIAL OFFICER | Sell | 20,672 | $406,412 |
| 2025-11-24 | Theravance Biopharma, Inc. (TBPH) | SVP & CHIEF FINANCIAL OFFICER | Sell | 18,627 | $333,423 |
| 2025-08-22 | Theravance Biopharma, Inc. (TBPH) | SVP & CHIEF FINANCIAL OFFICER | Sell | 9,368 | $125,438 |
| 2025-05-22 | Theravance Biopharma, Inc. (TBPH) | SVP & CHIEF FINANCIAL OFFICER | Sell | 9,348 | $88,339 |
来源：SEC Form 4 申报文件 · 截至 2026-09-24